论文部分内容阅读
血浆工业的现状在最近的12个月内,3家欧洲利润性血浆分离工厂已扩大其生产能力,在澳大利亚、西德、比利时、荷兰、瑞士和法国的红十字会或政府机构中,大多数计划正在扩大中。据报告,在加拿大、中国、英国、希腊、意大利和朝鲜已计划或实际在组建新血浆分离工厂。这样一来增加的血浆分离能力约达250万升血浆/年。这一情况提示,人们并未虑及不久会出现重组DNA(rDNA)有取代血浆衍
The current state of the plasma industry In the last 12 months, three European profitable plasma separation plants have expanded their production capacity, with most of the Red Cross or government agencies in Australia, West Germany, Belgium, the Netherlands, Switzerland and France. Plans are expanding. According to reports, new plasma separation plants have been planned or actually established in Canada, China, the United Kingdom, Greece, Italy and North Korea. This increased plasma separation capacity by approximately 2.5 million liters of plasma/year. This situation suggests that people did not consider that there will soon be recombinant DNA (rDNA) substituted for plasma.